Renee Leck | Investor Relations |
Bobby Gaspar | Chief Executive Officer |
Frank Thomas | Chief Operating Officer |
Yaron Werber | Cowen |
Anupam Rama | JP Morgan |
Peter Kim | Barclays |
David Nierengarten | Wedbush Securities |
Anna Vorobyeva-Schiano | Goldman Sachs |
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Orchard Therapeutics Second Quarter 2020 Earnings Conference Call. [Operator instructions] At this time, I would like to turn the conference over to Ms. Renee Leck, Director of Investor Relations. Please begin, ma'am.